Balanced news tone
News Sentiment
GDRX sentiment intelligence
Goodrx Holdings Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
78/100 classification confidence.
directly relevant articles
high-authority source matches
-3.3% over one week, +11.3% over four weeks, trend active, and below fair value.
Stocks making big moves yesterday: RXO, Progyny, Cigna, GoodRx, and Domino's
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Stocks making big moves yesterday: RXO, Progyny, Cigna, GoodRx, and Domino's
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 20:07
- Source
- StockStory
GoodRx (GDRX) Stock Trades Up, Here Is Why
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 23:50
- Source
- Market source
GoodRx Holdings (GDRX) Pharma Growth Story Meets A Small Fair Value Gap
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 12 Jul 2026 05:07
- Source
- Market source
GoodRx (GDRX) Stock Looks Full On Earnings But Mixed On Value
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 Jul 2026 07:10
- Source
- Market source
GoodRx Holdings (GDRX) Sets Q2 Results Date, Is The Stock Still Undervalued?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 Jul 2026 02:31
- Source
- simplywall.st
GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 09 Jul 2026 20:05
- Source
- Business Wire
GoodRx sets Aug. 5 earnings release, Aug. 6 call
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 09 Jul 2026 20:05
- Source
- Stock Titan
GoodRx (GDRX) Upgraded to Buy: What Does It Mean for the Stock?
- Tone
- Positive 84/100
- Event
- Analyst action
- Published
- 08 Jul 2026 16:00
- Source
- Market source
Is GoodRx (GDRX) Stock Undervalued Right Now?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 13:40
- Source
- Market source
3 Penny Stocks Under $8B Market Cap Worth Watching
This article highlights three penny stocks with market caps under $8 billion that are worth watching, despite the current positive trend in the U.S. market. It examines GoodRx Holdings (GDRX), CI&T (CINT), and Snap (SNAP), detailing their financial health, operational revenue, an
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 03 Jul 2026 11:10
- Source
- Sahm
GoodRx Holdings, Inc. Class A Actuals & Estimates (NASDAQ:GDRX)
This article provides a detailed financial overview and analyst estimates for GoodRx Holdings, Inc. (NASDAQ: GDRX). It covers stock performance, price targets, earnings reports, revenue, market capitalization, and volatility. The company's stock price recently decreased by -2.54%
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Jun 2026 22:09
- Source
- TradingView
GoodRx Holdings elects directors and ratifies auditor at annual meeting
GoodRx Holdings, Inc. held its Annual Meeting of Stockholders, where shareholders elected three Class III directors, ratified KPMG LLP as its independent auditor for fiscal year 2026, and approved executive officer compensation on an advisory basis. The company, trading at $2.68
- Tone
- Positive 64/100
- Event
- Market update
- Published
- 19 Jun 2026 03:09
- Source
- Investing.com
GoodRx (NASDAQ: GDRX) investors re-elect board and ratify KPMG, back pay
GoodRx Holdings, Inc. announced the results of its annual stockholder meeting held on June 16, 2026. Stockholders re-elected Wendy Barnes, Ronald E. Bruehlman, and Gregory Mondre as Class III directors, ratified KPMG LLP as the independent registered public accounting firm for th
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Jun 2026 20:05
- Source
- Stock Titan
GoodRx (GDRX) director receives 73,434 RSUs vesting by 2027 meeting
GoodRx Holdings director Kelly J. Kennedy received an equity award of 73,434 restricted stock units (RSUs) of Class A common stock, which were granted at no cash cost. These RSUs will vest in full on the earlier of the one-year anniversary of June 16, 2026, or the 2027 Annual Mee
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 18 Jun 2026 00:39
- Source
- Stock Titan
GoodRx (GDRX) director Trevor Bezdek granted 73,434 RSUs and updates holdings
GoodRx Holdings director Trevor Bezdek was granted 73,434 restricted stock units (RSUs) as compensation, vesting on June 16, 2026, or the 2027 Annual Meeting, subject to continued service. Following this grant, Bezdek directly holds 343,810 Class A shares and has indirect interes
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 00:39
- Source
- Stock Titan
[Form 4] GoodRx Holdings, Inc. Insider Trading Activity
GoodRx Holdings, Inc. director Ronald E. Bruehlman reported an acquisition of 73,434 deferred stock units, increasing his direct holdings to 207,352 shares. These units vest on the earlier of one year from June 16, 2026, or the 2027 Annual Meeting, and settle into shares upon spe
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 18 Jun 2026 00:39
- Source
- Stock Titan
GoodRx (GDRX) director Douglas Hirsch receives 73,434 deferred stock units in equity grant
GoodRx Holdings, Inc. director Douglas Hirsch has been granted 73,434 deferred stock units as part of an equity compensation package. These units, which represent a right to one share each, will vest on the earlier of June 16, 2027, or the company's 2027 annual stockholders' meet
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 00:39
- Source
- Stock Titan
Q1 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jun 2026 07:00
- Source
- Market source
GoodRx (GDRX) AGM 2026 Summary
This article summarizes the GoodRx (GDRX) Annual General Meeting (AGM) held on June 16, 2026. Key agenda items included the nomination of Class C directors, ratification of KPMG LLP as the auditor, and advisory approval of executive compensation. The report also highlights recent
- Tone
- Positive 65/100
- Event
- Regulatory and legal
- Published
- 16 Jun 2026 23:09
- Source
- Quartr
GoodRx Holdings Inc (GDRX) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for GoodRx Holdings Inc (GDRX), highlighting its current earnings forecast score of 6.67 and an average price target of $5.00 from 15 analysts. The company's expected revenue for the next quarter is $193.16 million, with most analysts re
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jun 2026 12:09
- Source
- TradingKey
GoodRx (GDRX) Chief Accounting Officer exercises RSUs, shares withheld for taxes
GoodRx Holdings, Inc.'s Chief Accounting Officer, Thomas Chan, engaged in routine equity compensation activity, exercising 4,069 restricted stock units (RSUs) into Class A common stock on June 15, 2026. To cover tax obligations arising from this transaction, 2,071 shares were wit
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 20:39
- Source
- Stock Titan
Trevor Bezdek (GDRX) receives 110K RSUs vesting in 2027
GoodRx Holdings, Inc. director Trevor Bezdek was granted 110,294 restricted stock units (RSUs), each representing one share of Class A common stock, at a price of $0.00 per unit. These RSUs will vest 100% on December 31, 2027, contingent on his continued service. Following this t
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 00:39
- Source
- Stock Titan
GoodRx Holdings, Inc. (GDRX) Strengthens Recurring Revenue Base with Companion
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Jun 2026 07:00
- Source
- Market source
GoodRx (NASDAQ: GDRX) director receives 4,642 deferred stock units
GoodRx (NASDAQ: GDRX) director Ronald E. Bruehlman was granted 4,642 deferred stock units at no cash cost. These units, representing a contingent right to one share of Class A common stock each, will vest 2% on May 31, 2026, with the remainder vesting monthly over seven months, s
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 29 May 2026 22:09
- Source
- Stock Titan
GoodRx (NASDAQ: GDRX) director grant adds 4,642 deferred stock units
GoodRx Holdings, Inc. director Douglas Joseph Hirsch was granted 4,642 deferred stock units at a price of $0.00 per share on May 27, 2026. This grant increases his direct holdings to 247,502 shares of Class A common stock. The units have a vesting schedule where 2% vest on May 31
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 22:09
- Source
- Stock Titan
How The Shifting Story For GoodRx (GDRX) Is Reshaping Analyst Views And Valuation
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 28 May 2026 07:00
- Source
- Market source
GoodRx: TrumpRx Exposes Legacy Moat Breach And Zero-Sum Strategy (Downgrade) (NASDAQ:GDRX)
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 20 May 2026 07:00
- Source
- Seeking Alpha
GoodRx (GDRX) CAO exercises RSUs and delivers shares to cover taxes
GoodRx Holdings, Inc.'s Chief Accounting Officer, Thomas Chan, exercised 5,575 restricted stock units, converting them into Class A common stock. To cover tax obligations related to these vestings, 2,838 shares were disposed of at $2.49 per share through a non-market, tax-withhol
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 May 2026 21:10
- Source
- Stock Titan
GoodRx (NASDAQ: GDRX) executive exercises 44,779 RSUs, 19,726 shares for taxes
GoodRx Holdings executive Christopher A. McGinnis exercised 44,779 restricted stock units to acquire Class A common stock and concurrently surrendered 19,726 shares to cover tax obligations. These routine transactions are related to equity compensation and not open-market sales.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 May 2026 21:10
- Source
- Stock Titan
Some May Be Optimistic About GoodRx Holdings' (NASDAQ:GDRX) Earnings
Despite soft profit numbers, GoodRx Holdings' recent earnings report pleased the market due to signs of underlying promise. The company's profit was notably reduced by US$14 million due to unusual, likely one-off, items, suggesting its true earnings potential might be understated
- Tone
- Positive 60/100
- Event
- Earnings
- Published
- 15 May 2026 04:39
- Source
- Sahm